19-12581362-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020714.3(ZNF490):c.713G>A(p.Arg238Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020714.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF490 | ENST00000311437.11 | c.713G>A | p.Arg238Gln | missense_variant | 5/5 | 1 | NM_020714.3 | ENSP00000311521.6 | ||
ZNF490 | ENST00000414906.5 | n.*635G>A | non_coding_transcript_exon_variant | 6/6 | 3 | ENSP00000402719.1 | ||||
ZNF490 | ENST00000414906.5 | n.*635G>A | 3_prime_UTR_variant | 6/6 | 3 | ENSP00000402719.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151708Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251360Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135850
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461820Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 727208
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151708Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74058
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.713G>A (p.R238Q) alteration is located in exon 5 (coding exon 5) of the ZNF490 gene. This alteration results from a G to A substitution at nucleotide position 713, causing the arginine (R) at amino acid position 238 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at